In case you missed it, Joe Grogan, visiting senior fellow at the USC Schaeffer Center and former domestic policy adviser under the previous administration, asked Members of Congress a critical question in a new op-ed published in Townhall: Congress wants
In case you missed it, former U.S. Senator Pat Toomey (R-PA) warns Republican policymakers against passing unvetted and disastrous policies targeting pharmacy benefits being debated in Washington, in a new op-ed published in The Washington Times. Toomey writes: “Giant, must-pass
(Washington D.C.) – Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s Senate Finance Committee hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” “PCMA commends the Senate Finance Committee
Executive Vice President CVS Health and President CVS Caremark, and PCMA Chairman of the Board David Joyner is executive vice president of CVS Health and president of CVS Caremark. He leads the Pharmacy Services segment, which provides solutions to employers,
Adam Kautzner, Pharm.D. President, Express Scripts Adam Kautzner is President of Express Scripts, one of the nation’s leading pharmacy benefit management (PBM) companies that serves more than 112 million Americans. Express Scripts is part of Evernorth, which connects and coordinates
Legislation Would Limit Options for Employers to Provide Quality Prescription Drug Coverage for Employees The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee is weighing several proposed policies related to the prescription drug market, including S. 1339, the Pharmacy
With so many important issues being debated today, there are few topics that health care, legal, and economic experts agree on. But the fact that drug companies are the root cause of high prescription drug prices is one common denominator
©2024 PCMA. All Rights Reserved.
